Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2023-02-10 00:00:00 ET · period of report 2023-02-08 · accession 0001367644-23-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-10 | 2023-02-08 | EBS | LINDAHL RICHARD S | EVP, CFO | A - Grant | $0.00 | +101 | 21.8K | +0.5% | $0 | |
| 2023-02-10 | 2023-02-08 | EBS | LINDAHL RICHARD S | EVP, CFO | F - Tax | $13.25 | -2,396 | 19.4K | -11% | -$31.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-08 | A | A | 101 | $0.00 | 21,797 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-08 | F | D | 2,396 | $13.25 | 19,401 | D | — | — |